[ Price : $8.95]
Reuters reports that several drug companies say they are using artificial intelligence tools to speed up some of the time-intensiv...[ Price : $8.95]
FDA approves a Scancell Holdings IND to begin a registrational Phase 3 trial of iSCIB1+ in patients with advanced melanoma.[ Price : $8.95]
A federal judge sentences former CytoDyn chief executive Nader Pourhassan to 30 months in prison for misleading investors about th...[ Price : $8.95]
FDA cites Pine Pharmaceuticals for multiple quality and sterility violations following a 10-day inspection of the companys drug ou...[ Price : $8.95]
A Health Affairs analysis on FDAs new pathway allowing drug approvals based on a plausible mechanism of action warns that the appr...[ Price : $8.95]
Sarepta Therapeutics announces that its gene therapy Elevidys significantly slowed disease progression over three years in ambulat...[ Price : $8.95]
AMT-130 is a gene therapy designed to lower levels of the mutant huntingtin protein believed to drive Huntingtons disease progress...[ Price : $8.95]
U.S., U.K. and Canadian drug regulators announce a joint international symposium to discuss evolving regulatory expectations for c...